{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T18:10:08Z","timestamp":1785435008573,"version":"3.56.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T00:00:00Z","timestamp":1635206400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T00:00:00Z","timestamp":1635206400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"operational grant of guangdong provincial key laboratory","award":["2017B030314019"],"award-info":[{"award-number":["2017B030314019"]}]},{"name":"key laboratory of national health commission"},{"name":"key laboratory of nephrology, guangdong province, guangzhou, china","award":["2002B60118"],"award-info":[{"award-number":["2002B60118"]}]},{"DOI":"10.13039\/501100003453","name":"guangdong natural science foundation","doi-asserted-by":"crossref","award":["2020A1515010241"],"award-info":[{"award-number":["2020A1515010241"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the natural science foundation of guangdong province, china","award":["2017A030310199"],"award-info":[{"award-number":["2017A030310199"]}]},{"name":"5010 clinical program of sun yat-sen university","award":["2017007"],"award-info":[{"award-number":["2017007"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s10238-021-00768-y","type":"journal-article","created":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T12:17:42Z","timestamp":1635250662000},"page":"455-464","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Clinical characteristics and outcomes of idiopathic membranous nephropathy with glomerular IgM deposits"],"prefix":"10.1007","volume":"22","author":[{"given":"Xu","family":"Yu-Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huang","family":"Na-Ya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu","family":"Ya-Gui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Xiong-Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhi-Jian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5016-6653","authenticated-orcid":false,"given":"Wang","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,26]]},"reference":[{"issue":"9981","key":"768_CR1","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1016\/s0140-6736(15)60731-0","volume":"385","author":"P Ronco","year":"2015","unstructured":"Ronco P, Debiec H. Pathophysiological advances in membranous nephropathy: time for a shift in patient\u2019s care. The Lancet. 2015;385(9981):1983\u201392. https:\/\/doi.org\/10.1016\/s0140-6736(15)60731-0.","journal-title":"The Lancet"},{"issue":"8","key":"768_CR2","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1111\/nep.12542","volume":"20","author":"P Zhu","year":"2015","unstructured":"Zhu P, Zhou FD, Wang SX, Zhao MH, Wang HY. Increasing frequency of idiopathic membranous nephropathy in primary glomerular disease: a 10-year renal biopsy study from a single Chinese nephrology centre. Nephrology (Carlton). 2015;20(8):560\u20136. https:\/\/doi.org\/10.1111\/nep.12542.","journal-title":"Nephrology (Carlton)"},{"issue":"12","key":"768_CR3","doi-asserted-by":"publisher","first-page":"3739","DOI":"10.1681\/ASN.2016010093","volume":"27","author":"X Xu","year":"2016","unstructured":"Xu X, Wang G, Chen N, et al. Long-term exposure to air pollution and increased risk of membranous nephropathy in China. J Am Soc Nephrol. 2016;27(12):3739\u201346. https:\/\/doi.org\/10.1681\/ASN.2016010093.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"768_CR4","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1053\/j.ajkd.2008.06.006","volume":"52","author":"CH Zeng","year":"2008","unstructured":"Zeng CH, Chen HM, Wang RS, et al. Etiology and clinical characteristics of membranous nephropathy in Chinese patients. Am J Kidney Dis. 2008;52(4):691\u20138. https:\/\/doi.org\/10.1053\/j.ajkd.2008.06.006.","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"768_CR5","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s00281-014-0423-y","volume":"36","author":"H Debiec","year":"2014","unstructured":"Debiec H, Ronco P. Immunopathogenesis of membranous nephropathy: an update. Semin Immunopathol. 2014;36(4):381\u201397. https:\/\/doi.org\/10.1007\/s00281-014-0423-y.","journal-title":"Semin Immunopathol"},{"issue":"5","key":"768_CR6","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1681\/ASN.2005010096","volume":"16","author":"PN Cunningham","year":"2005","unstructured":"Cunningham PN, Quigg RJ. Contrasting roles of complement activation and its regulation in membranous nephropathy. J Am Soc Nephrol. 2005;16(5):1214\u201322. https:\/\/doi.org\/10.1681\/ASN.2005010096.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"768_CR7","first-page":"183","volume":"11","author":"W Heymann","year":"2000","unstructured":"Heymann W, Hackel DB, Harwood S, Wilson SG, Hunter JL. Production of nephrotic syndrome in rats by Freund's adjuvants and rat kidney suspensions. 1951. J Am Soc Nephrol. 2000 Jan;11(1):183-8. \u00a0","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"768_CR8","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1172\/jci109987","volume":"66","author":"S Dj","year":"1980","unstructured":"Dj S. S B, MP M, investigation C W J T J o c: A new role for complement in experimental membranous nephropathy in rats. J Clin Invest. 1980;66(6):1339\u201350. https:\/\/doi.org\/10.1172\/jci109987.","journal-title":"J Clin Invest"},{"issue":"1","key":"768_CR9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa0810457","volume":"361","author":"HB Laurence","year":"2009","unstructured":"Laurence HB, Bonegio RG, Lambeau G, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med. 2009;361(1):11\u201321. https:\/\/doi.org\/10.1056\/NEJMoa0810457.","journal-title":"N Engl J Med"},{"issue":"24","key":"768_CR10","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1056\/NEJMoa1409354","volume":"371","author":"NM Tomas","year":"2014","unstructured":"Tomas NM, Beck LH Jr, Meyer-Schwesinger C, et al. Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy. N Engl J Med. 2014;371(24):2277\u201387. https:\/\/doi.org\/10.1056\/NEJMoa1409354.","journal-title":"N Engl J Med"},{"issue":"4","key":"768_CR11","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1093\/ndt\/14.4.881","volume":"14","author":"K Lhotta","year":"1999","unstructured":"Lhotta K, Wurzner R, Konig P. Glomerular deposition of mannose-binding lectin in human glomerulonephritis. Nephrol Dial Transplant. 1999;14(4):881\u20136. https:\/\/doi.org\/10.1093\/ndt\/14.4.881.","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"768_CR12","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1093\/ndt\/gfx235","volume":"33","author":"N Hayashi","year":"2018","unstructured":"Hayashi N, Okada K, Matsui Y, et al. Glomerular mannose-binding lectin deposition in intrinsic antigen-related membranous nephropathy. Nephrol Dial Transplant. 2018;33(5):832\u201340. https:\/\/doi.org\/10.1093\/ndt\/gfx235.","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"768_CR13","first-page":"415","volume":"64","author":"JS van der Zee","year":"1986","unstructured":"van der Zee JS, van Swieten P, Aalberse RC. Inhibition of complement activation by IgG4 antibodies. Clin Exp Immunol. 1986;64(2):415\u201322.","journal-title":"Clin Exp Immunol."},{"issue":"1","key":"768_CR14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1046\/j.0019-2805.2001.01341.x","volume":"105","author":"RC Aalberse","year":"2002","unstructured":"Aalberse RC, Schuurman J. IgG4 breaking the rules. Immunology. 2002;105(1):9\u201319. https:\/\/doi.org\/10.1046\/j.0019-2805.2001.01341.x.","journal-title":"Immunology"},{"issue":"6","key":"768_CR15","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/modpathol.2012.237","volume":"26","author":"CC Huang","year":"2013","unstructured":"Huang CC, Lehman A, Albawardi A, et al. IgG subclass staining in renal biopsies with membranous glomerulonephritis indicates subclass switch during disease progression. Mod Pathol. 2013;26(6):799\u2013805. https:\/\/doi.org\/10.1038\/modpathol.2012.237.","journal-title":"Mod Pathol"},{"issue":"3","key":"768_CR16","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1093\/ndt\/gfs491","volume":"28","author":"X Kong","year":"2013","unstructured":"Kong X, Ma Y, Chen J, et al. Evaluation of the chronic kidney disease epidemiology collaboration equation for estimating glomerular filtration rate in the chinese population. Nephrol Dial Transplant. 2013;28(3):641\u201351. https:\/\/doi.org\/10.1093\/ndt\/gfs491.","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"768_CR17","first-page":"227","volume":"80","author":"C Kaplan","year":"1975","unstructured":"Kaplan C, Pasternack B, Shah H, Gallo G. Age-related incidence of sclerotic glomeruli in human kidneys. Am J Pathol. 1975;80(2):227\u201334.","journal-title":"Am J Pathol"},{"issue":"5","key":"768_CR18","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1038\/ki.1987.122","volume":"31","author":"BL Kasiske","year":"1987","unstructured":"Kasiske BL. Relationship between vascular disease and age-associated changes in the human kidney. Kidney Int. 1987;31(5):1153\u20139. https:\/\/doi.org\/10.1038\/ki.1987.122.","journal-title":"Kidney Int"},{"issue":"3","key":"768_CR19","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1053\/j.ajkd.2013.06.002","volume":"62","author":"L Beck","year":"2013","unstructured":"Beck L, Bomback AS, Choi MJ, Holzman LB, Langford C, Mariani LH, Somers MJ, Trachtman H, Waldman M. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for glomerulonephritis. Am J Kidney Dis. 2013;62(3):403\u201341. https:\/\/doi.org\/10.1053\/j.ajkd.2013.06.002.","journal-title":"Am J Kidney Dis."},{"issue":"1","key":"768_CR20","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1056\/NEJMoa1814427","volume":"381","author":"FC Fervenza","year":"2019","unstructured":"Fervenza FC, Appel GB, Barbour SJ, et al. Rituximab or cyclosporine in the treatment of membranous nephropathy. N Engl J Med. 2019;381(1):36\u201346. https:\/\/doi.org\/10.1056\/NEJMoa1814427.","journal-title":"N Engl J Med"},{"issue":"9","key":"768_CR21","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.2215\/CJN.01190216","volume":"11","author":"YM Zhang","year":"2016","unstructured":"Zhang YM, Gu QH, Huang J, et al. Clinical significance of IgM and C3 glomerular deposition in primary focal segmental glomerulosclerosis. Clin J Am Soc Nephrol. 2016;11(9):1582\u20139. https:\/\/doi.org\/10.2215\/CJN.01190216.","journal-title":"Clin J Am Soc Nephrol"},{"key":"768_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-021-00703-1","author":"L Tan","year":"2021","unstructured":"Tan L, Tang Y, Pei GQ, et al. Mesangial IgM deposition predicts renal outcome in patients with IgA nephropathy: a multicenter, observational study. Clin Exp Med. 2021. https:\/\/doi.org\/10.1007\/s10238-021-00703-1.","journal-title":"Clin Exp Med"},{"issue":"4","key":"768_CR23","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3325\/cmj.2017.58.281","volume":"58","author":"A Pacic","year":"2017","unstructured":"Pacic A, Senjug P, Bacalja J, et al. IgM as a novel predictor of disease progression in secondary focal segmental glomerulosclerosis. Croat Med J. 2017;58(4):281\u201391. https:\/\/doi.org\/10.3325\/cmj.2017.58.281.","journal-title":"Croat Med J"},{"issue":"2","key":"768_CR24","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1053\/ajkd.2003.50042","volume":"41","author":"J Myllym\u00e4ki","year":"2003","unstructured":"Myllym\u00e4ki J, Saha H, Mustonen J, Helin H, Pasternack A. IgM nephropathy: clinical picture and long-term prognosis. Am J Kidney Dis. 2003;41(2):343\u201350. https:\/\/doi.org\/10.1053\/ajkd.2003.50042.","journal-title":"Am J Kidney Dis."},{"issue":"3","key":"768_CR25","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1046\/j.1442-200x.2001.01396.x","volume":"43","author":"PM Zeis","year":"2001","unstructured":"Zeis PM, Kavazarakis E, Nakopoulou L, Moustaki M, Messaritaki A, Zeis MP, Nicolaidou P. Glomerulopathy with mesangial IgM deposits: long-term follow up of 64 children. Pediatr Int. 2001;43(3):287\u201392. https:\/\/doi.org\/10.1046\/j.1442-200x.2001.01396.x.","journal-title":"Pediatr Int."},{"issue":"2","key":"768_CR26","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1159\/000167950","volume":"9","author":"H Saha","year":"1989","unstructured":"Saha H, Mustonen J, Pasternack A, Helin H. Clinical follow-up of 54 patients with IgM-nephropathy. Am J Nephrol. 1989;9(2):124\u20138. https:\/\/doi.org\/10.1159\/000167950.","journal-title":"Am J Nephrol"},{"issue":"1","key":"768_CR27","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/ki.1984.14","volume":"25","author":"Y Ji-Yun","year":"1984","unstructured":"Ji-Yun Y, Melvin T, Sibley R, Michael A. No evidence for a specific role of IgM in mesangial proliferation of idiopathic nephrotic syndrome. Kidney Int. 1984;25(1):100\u20136. https:\/\/doi.org\/10.1038\/ki.1984.14.","journal-title":"Kidney Int"},{"issue":"35","key":"768_CR28","doi-asserted-by":"publisher","first-page":"14960","DOI":"10.1073\/pnas.0903805106","volume":"106","author":"D Czajkowsky","year":"2009","unstructured":"Czajkowsky D, Shao Z. The human IgM pentamer is a mushroom-shaped molecule with a flexural bias. Proceed Natl Acad Sci. 2009;106(35):14960\u20135. https:\/\/doi.org\/10.1073\/pnas.0903805106.","journal-title":"Proceed Natl Acad Sci"},{"issue":"3","key":"768_CR29","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1681\/ASN.2012020187","volume":"24","author":"D Strassheim","year":"2013","unstructured":"Strassheim D, Renner B, Panzer S, et al. IgM contributes to glomerular injury in FSGS. J Am Soc Nephrol. 2013;24(3):393\u2013406. https:\/\/doi.org\/10.1681\/ASN.2012020187.","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"768_CR30","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.imbio.2006.06.011","volume":"211","author":"ME McMullen","year":"2006","unstructured":"McMullen ME, Hart ML, Walsh MC, et al. Mannose-binding lectin binds IgM to activate the lectin complement pathway in vitro and in vivo. Immunobiology. 2006;211(10):759\u201366. https:\/\/doi.org\/10.1016\/j.imbio.2006.06.011.","journal-title":"Immunobiology"},{"issue":"11","key":"768_CR31","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1136\/jcp.33.11.1029","volume":"33","author":"W Lawler","year":"1980","unstructured":"Lawler W, Williams G, Tarpey P, Mallick N. IgM associated primary diffuse mesangial proliferative glomerulonephritis. J Clin Pathol. 1980;33(11):1029\u201338. https:\/\/doi.org\/10.1136\/jcp.33.11.1029.","journal-title":"J Clin Pathol"},{"issue":"3","key":"768_CR32","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/j.1365-2559.1984.tb02355.x","volume":"8","author":"HC Hsu","year":"1984","unstructured":"Hsu HC, Chen WY, Lin GJ, Chen L, Kao SL, Huang CC, Lin CY. Clinical and immunopathologic study of mesangial IgM nephropathy: report of 41 cases. Histopathol. 1984;8(3):435\u201346. https:\/\/doi.org\/10.1111\/j.1365-2559.1984.tb02355.x.","journal-title":"Histopathol"},{"issue":"6","key":"768_CR33","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1159\/000182071","volume":"27","author":"T Cavallo","year":"1981","unstructured":"Cavallo T, Johnson M. Immunopathologic study of minimal change glomerular disease with mesangial IgM deposits. Nephron. 1981;27(6):281\u20134. https:\/\/doi.org\/10.1159\/000182071.","journal-title":"Nephron"},{"issue":"9","key":"768_CR34","doi-asserted-by":"publisher","first-page":"e0136558","DOI":"10.1371\/journal.pone.0136558","volume":"10","author":"JM Thurman","year":"2015","unstructured":"Thurman JM, Wong M, Renner B, et al. Complement activation in patients with focal segmental glomerulosclerosis. PLoS One. 2015;10(9):e0136558. https:\/\/doi.org\/10.1371\/journal.pone.0136558.","journal-title":"PLoS One"},{"issue":"3","key":"768_CR35","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/ki.2015.120","volume":"88","author":"SE Panzer","year":"2015","unstructured":"Panzer SE, Laskowski J, Renner B, et al. IgM exacerbates glomerular disease progression in complement-induced glomerulopathy. Kidney Int. 2015;88(3):528\u201337. https:\/\/doi.org\/10.1038\/ki.2015.120.","journal-title":"Kidney Int"},{"issue":"1","key":"768_CR36","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/nri2901","volume":"11","author":"N Baumgarth","year":"2011","unstructured":"Baumgarth N. The double life of a B-1 cell: self-reactivity selects for protective effector functions. Nat Rev Immunol. 2011;11(1):34\u201346. https:\/\/doi.org\/10.1038\/nri2901.","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"768_CR37","doi-asserted-by":"publisher","first-page":"4389","DOI":"10.4049\/jimmunol.174.7.4389","volume":"174","author":"Y Hamaguchi","year":"2005","unstructured":"Hamaguchi Y, Uchida J, Cain DW, et al. The peritoneal cavity provides a protective niche for B1 and conventional B lymphocytes during anti-CD20 immunotherapy in mice. J Immunol. 2005;174(7):4389\u201399. https:\/\/doi.org\/10.4049\/jimmunol.174.7.4389.","journal-title":"J Immunol"},{"issue":"4","key":"768_CR38","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.ijpam.2019.09.001","volume":"6","author":"DM Al Romaili","year":"2019","unstructured":"Al Romaili DM, Al-Hussain TO, Awad HS, et al. Clinical significance of IgM deposition in pediatric minimal change disease. Int J Pediatr Adolesc Med. 2019;6(4):146\u201350. https:\/\/doi.org\/10.1016\/j.ijpam.2019.09.001.","journal-title":"Int J Pediatr Adolesc Med"},{"issue":"6","key":"768_CR39","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/ki.2010.460","volume":"79","author":"K El Karoui","year":"2011","unstructured":"El Karoui K, Hill GS, Karras A, et al. Focal segmental glomerulosclerosis plays a major role in the progression of IgA nephropathy. II. Light microscopic and clinical studies. Kidney Int. 2011;79(6):643\u201354. https:\/\/doi.org\/10.1038\/ki.2010.460.","journal-title":"Kidney Int"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-021-00768-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-021-00768-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-021-00768-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T11:20:22Z","timestamp":1659093622000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-021-00768-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,26]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["768"],"URL":"https:\/\/doi.org\/10.1007\/s10238-021-00768-y","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,26]]},"assertion":[{"value":"3 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This research complied with the Declaration of Helsinki and was approved by the Ethics Committee of Sun Yat-Sen University [EC No. 2019482].","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"This study used the data obtained in the previous clinical practice, which has little risk to the subjects, so informed consent was waived, which was approved by the Ethics Committee of Sun Yat-Sen University.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The data are anonymous, and informed consent was therefore waived.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}